| Series |
Current controversies
|
| Bibliography |
Includes bibliographical references (p. 227-235) and index. |
| Contents |
Is too little attention given to the safety of prescription drugs? Yes : Problems often show up after a prescription drug is on the market. Off-label prescription of drugs can lead to adverse effects / Hazel Muir -- Some prescription drugs on the market are unsafe / Consumer reports -- Prescription drugs can cause serious harm when risks are ignored / Susan Kelleher -- Post-marketing study of prescription drugs is not adequate / David J. Graham -- No : Too much caution deprives patients of prescription drugs they need. Excessive caution in drug approval causes more harm than it prevents / Scott Gottlieb -- Panic over prescription-drug risks leads people to stop taking needed medication / Irene S. Levine -- Safety concerns about prescription drugs are exaggerated and will result in higher prices / Henry I. Miller -- Lengthy approval process for prescription drugs costs lives / Gilbert L. Ross -- Terminally ill patients should be allowed to use experimental drugs / Sigrid Fry-Revere -- Do pharmaceutical companies promote unnecessary drugs? Direct-to-consumer prescription drug advertising : an overview / Carol Rados -- Yes : Many new drugs are developed merely for commercial reasons. Pharmaceutical companies define normal conditions as diseases / Ray Moynihan, Alan Cassels -- Drug promotion plays on people's fears of future illness / Barbara Mintzes -- Drug promotion has led to the overmedication of children / Anne Taylor Fleming -- No : New drugs help people who would otherwise lack effective treatment. Drugs for minor conditions are important to many people / Glenn Harlan Reynolds -- Improved prescription drugs mean better medical treatment and less illness / Alan F. Holmer -- Direct-to-consumer prescription drug advertising helps people get treatment for undiagnosed diseases / Paul Antony -- |
|
Do prescription drugs in America cost too much? Rising cost of prescription drugs : an overview -- Yes : American pharmaceutical companies charge too much. Many people cannot afford the prices set by the profit-driven drug industry / Katharine Greider -- Importing less-costly prescription drugs from abroad should be allowed / Nelda Barnett -- New cancer drugs cost more than their brief extending of life may be worth / Daniel Costello -- No : pharmaceutical companies need profits to do research. High prices of drugs for minor problems pay for drugs that cure more serious ones / Peter W. Huber -- Medical innovation would stop if the government controlled drug prices / Sidney Taurel -- Controlling drug prices would reduce access to medicine / Doug Bandow -- Are dishonest or illegal prescription drug practices common? Gifts from pharmaceutical companies influence doctors / Adriane Fugh-Berman, Shahram Ahari -- Media reporting about prescription drugs is often inaccurate / Richard A. Deyo, Donald L. Patrick -- Prescription drugs are often abused / Nichole Aksamit -- Young people often trade prescription drugs with friends / Amy Harmon -- Teens use prescription drugs to get high / Donna Leinwand. |
| Access |
Access limited to licensed institutions. |
| Subject |
Drugs -- Public opinion.
|
|
Pharmaceutical industry.
|
|
Pharmaceutical policy.
|
| Genre/Form |
Electronic books.
|
| Added Author |
Engdahl, Sylvia.
|
| ISBN |
9780737739626 (hardcover) |
|
0737739622 (hardcover) |
|
9780737739633 (pbk.) |
|
